Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Press Releases

Latest Press Releases

Vax_CAR_Measles_MagaliDeppen_2015_MSF152051 Photograph by Magali Deppen
Press release
Press release |
13 January 2016
Vaccines
Central African Republic

Central African Republic (CAR): MSF launches vaccination campaign of unprecedented scale

Ebola survivor, Jesse Wolatee, 65yrs, explains to an MSF Ebola survivor clinic staff post-Ebola syndrome she is experiencing. Photograph by Adolphus Mawolo
Press release
Press release |
07 January 2016
Malaria

Antimalarial Drug Reduced Risk of Dying Among Ebola Patients

2 min
For Richard knowing that if you cough for more then two weeks you should visit the hospital to get checked for TB was crucial. Photograph by Olga Victoire
Press release
Press release |
22 December 2015

MSF Response to U.S. Government's Release of "Action Plan" on Drug-Resistant Tuberculosis

3 min
Ubaldo Mendoza, 18, has initiated Chagas treatment in San Pedro Pochutlas health facility. Photograph by Consuelo Pagaza
Press release
Press release |
12 December 2015
Tropical & neglected diseases

MSF Statement on KaloBios Plan to Raise Price Of Drug To Treat Chagas Disease

4 min
Nurses prepare patients’ ‘directly observed treatment’ (DOT) in the pharmacy of the ambulatory ward at the National Centre for Tuberculosis and Lung Disease in Georgia’s capital, Tbilisi. Because drug-resistant tuberculosis treatments can be toxic and cause many side effects, patients must take their pills in front of a medical professional (usually a nurse) to ensure that they take all drugs, hence the treatment is ‘directly observed’. Photograph by Daro Sulakauri
Press release
Press release |
03 December 2015
Tuberculosis

First new TB drugs in half a century reach just 2% of people who need them

6 min
A patient infected with TB is treated by a member of MSF staff within a prison in Donetsk, Ukraine, where MSF is helping to treat patients infected with TB. Photograph by Manu Brabo
Press release
Press release |
02 December 2015
Tuberculosis

New survey shows outdated TB policies and practices risking further spread of drug-resistant TB

6 min
Stop Stock Outs (SSP) activists at the Stop Stock Outs (SSP) activist meeting in Soshanguve, a township outside of Pretoria on April 16, 2015. Photograph by Stefan Heunis
Press release
Press release |
30 November 2015
HIV/AIDS
South Africa

Antiretroviral drugs fail to consistently reach patients in countries most affected by HIV/AIDS

4 min
Living with HIV/AIDS – The Need for Treatment Support
Press release
Press release |
30 November 2015
HIV/AIDS
Kenya

HIV: Despite better access to treatment, many AIDS patients in African hospitals still die

4 min
  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury